Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe
Spotlight

Georgia Introduces Prescription Drug Reform Bill

The bill would allow payers to direct prescriptions to pharmacy networks and create limits for physician dispensing and compounds.
Read More →
February 9, 2026
Spotlight

Arizona Bill Could Expand Worker Choice in Medical Care

Senate Bill 1404 could grant workers greater choice over their provider, pharmacy, certain ancillary services, and more.
Read More →
February 9, 2026
Spotlight

Hawaii Bills Target Pharmacy Management Rules

New bills would address compounds, deadlines for authorization decisions, and more.
Read More →
February 2, 2026

Tennessee Medical Advisory Committee Meeting Recap

The meeting covered potential updates to treatment guidelines, specifically for physical therapy, as well as other topics.
Read More →
February 16, 2026

More States Continue to Introduce AI Healthcare Bills

Colorado, Georgia, Iowa, Illinois, and Rhode Island have introduced new bills, joining a growing national movement.
Read More →
February 16, 2026

Kansas Introduces Medical Marijuana Bill

The 115-page bill details qualifying conditions, registration processes, regulation boards, taxes, and much more.
Read More →
February 16, 2026

California Publishes Report on Psychotherapeutic and Neurological Drugs

While this drug class represents less than 1% of prescriptions, it accounted for 3.4% of drug spend.
Read More →
February 16, 2026

States Introduce Bills to Protect Workers from Extreme Temperatures

So far, Arizona, Georgia, and Virginia have introduced bills that would require workplace safety standards for heat protection.
Read More →
February 9, 2026

Hawaii Could Expand Firefighter Cancer Presumption

A proposed bill could add additional types of cancer to the pre-existing presumption for firefighters.
Read More →
February 9, 2026
1 2 3 … 45

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

The Cost of Exposure: How Occupational Cancer Impacts Workers’ Compensation

The risk and impact of occupational cancers vary significantly depending on the nature of the exposure and the affected workforce.
Read More

Utah Launches AI Prescription Renewal Pilot Program for Chronic Conditions

The pilot can approve a limited set of 192 medications and will be broken into three stages, each with different levels of review.
Read More

States Seek to Limit AI-Generated Care Decisions, Despite White House Order

Legislators continue to introduce bills to limit AI-generated healthcare decisions, even as the U.S. Attorney General has been instructed to oppose them.
Read More

White House Issues Executive Order to Reschedule Marijuana

Rescheduling marijuana to Schedule III will allow for greater clinical research, possible FDA-approved drugs, and more.
Read More

States Consider Expanding Presumptions

So far in 2026, eight states and counting are seeking to expand existing presumptions or create new presumptions.
Read More

Could AI-Designed Drugs Impact Regulatory Frameworks?

While AI can be effective in some elements of drug design, AI models currently struggle to explain their decision making, a key component of drug review.
Read More
1 2 3 … 49
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle